Traded Jun 24, 2026 · Filed Jun 25, 2026
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $160K of Becton Dickinson shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$160,226
Shares × reported transaction price
48 days after results of May 7, 2026, 43 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $147.77 on Jun 24, 2026, 5% above its 52-week low and 30% below its high, after a 3% rise over the previous 30 trading days
52-week range $140.71 (Jun 22, 2026) to $210.02 (Feb 6, 2026), 10% of the way up, from 251 adjusted closes. 30 trading days earlier: $143.15 on May 11, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.2% | +3.1% | -3.3% |
| 30 days | +1.9% | +1.4% | +0.5% |
| 90 days | +14.9% | +5.2% | +9.7% |
Past results only. Not a forecast.
3 different filers disclosed BDX within 90 days. Disclosed 116 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
